Swiss National Bank’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.85M | Sell |
42,600
-1,000
| -2% | -$43.4K | ﹤0.01% | 1845 |
|
|
2025
Q1 | $1.63M | Sell |
43,600
-700
| -2% | -$26.2K | ﹤0.01% | 1884 |
|
|
2024
Q4 | $2.01M | Buy |
44,300
+6,600
| +18% | +$299K | ﹤0.01% | 1851 |
|
|
2024
Q3 | $2.21M | Sell |
37,700
-4,500
| -11% | -$264K | ﹤0.01% | 1806 |
|
|
2024
Q2 | $1.66M | Buy |
42,200
+900
| +2% | +$35.4K | ﹤0.01% | 1911 |
|
|
2024
Q1 | $2.74M | Buy |
41,300
+8,300
| +25% | +$552K | ﹤0.01% | 1661 |
|
|
2023
Q4 | $922K | Buy |
+33,000
| New | +$922K | ﹤0.01% | 2283 |
|